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recent additions. From novel screens to identify path-
way genes, a number of apparently mammalian-specific
regulators may also be added to the list (Huangfu and
Anderson, 2006). In studying their function, one is sure
to find additional surprises and, with luck, additional
useful therapies.
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in Embryonic Stem Cell Growth
Neurotrophins act on embryonic cells through TRK re-
ceptors to inhibit apoptosis by phosphorylation of
AKT. In a recent paper in Nature Biotechnology, Pyle
et al. (2006) show that the presence of selected neuro-
trophins enables cloning of trypsinized single embry-
onic stem cells and potentially increases the availabil-
ity and usefulness of these stem cells.
Human embryonic stem cells (hESCs) are formed from
the inner cell mass (ICM) of developing blastocyst stage
preimplantation embryos (Reubinoff et al., 2000; Thom-
son et al., 1998). hESCs remain undifferentiated when
grown in tightly packed colonies in culture with mouse
embryonic fibroblasts (MEFs) (Reubinoff et al., 2000;
Thomson et al., 1998) or human embryonic fibroblasts
(Amit et al., 2003) and several other cell types. When
overgrown in culture or in the absence of live MEFs,
hESC colonies begin to differentiate, particularly at the
periphery and center of the colony. While MEF-condi-
tioned medium can be used to grow hESCs, it is difficult
to maintain euploidy and survival of undifferentiated
colonies. Passage of hESCs is done weekly or more of-
ten by mechanical division of the colony by using finely
drawn glass needles or scalpel fragments. Trypsiniza-
tion of the colonies and clonal derivation of the hESCs
has also been difficult and is commonly associated
with chromosomal abnormalities, high rates of cell
death, and differentiation (Pera, 2004). These technical
barriers have proved a limitation on hESC studies.
Leukemia inhibiting factor (LIF) is able to maintain
mouse ESCs by activation of the Jak/STAT signalingpathway in the absence of MEF feeders and facilitates
their renewal, clonal derivation, and genetic manipula-
tion. hESCs cannot be maintained by LIF, so it seems
likely that alternative signaling pathway(s) are used for
maintenance and growth of hESCs. A search for cyto-
kines that would enable large-scale, high-throughput
production of hESCs and their clonal derivation has
been a priority for human stem cell biology.
Pyle and colleagues set out to identify factors that
would promote the growth and survival of hESCs. In
their new study, just published in Nature Biotechnology
(Pyle et al., 2006), they describe a role for neurotrophins
in hESC maintenance and renewal. They examined mi-
croarray and SAGE data for evidence of the expression
of cell surface signaling receptors of tyrosine kinases,
and this analysis led to a focus on neurotrophins and
their receptors. Importantly, their discovery has enabled
Pyle et al. to develop a technique that improves the ef-
ficiency of clonal derivation of hESCs. This may well be
a very significant development in embryonic stem cell
biology.
Neurotrophins are a family of growth factors which in-
clude nerve growth factor, brain-derived nerve growth
factor, and neurotrophins (NT) 3 and 4. They act through
binding of their specific receptors: tropomyosin recep-
tor kinases (TRK; consisting of TRKA, TRKB and
TRKC) and p75 neurotrophin receptor (p75NGFR) (re-
viewed in Lu et al., [2005]). Pyle et al. thought the TRK
tyrosine kinase receptors ‘‘might act as receptors for
antiapoptotic factors’’ on hESCs. The lead for this hy-
pothesis is the need to maintain hESCs colonies at
>10 cells to retain their viability during passage on
MEFs or MEF-conditioned medium. Two hESC lines
(HI and H9) tested showed high levels of TRKB and
TRKC expression. TRKB binds BDNF and NT4, while
TRKC binds NT3 (Lu et al., 2005). Importantly, the MEF
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159feeder cells expressed mRNA for NGF, BDNF, NT3, and
NT4, hence the association of neurotrophins with the
maintenance and renewal of hESCs was established.
Pyle et al. demonstrate substantially increased survival
and colony formation when single hESCs are grown in
the presence of BDNF, NT3, and NT4, with or without
MEF cocultures. Antibodies to neurotrophins in MEF-
conditioned medium reduced cell survival and colony
formation. Pyle et al. also showed that the PI3K/AKT
signaling pathway is essential for the effects of neuro-
trophins in hESCs. Activation of the PI3K pathway is as-
sociated with cell survival (Cantley, 2002) and supports
the authors’ hypothesis of promotion of hESC survival
by neurotrophin inhibition of apoptosis.
Two additional lines of evidence also support the idea
of an important role for neurotrophins in hESC mainte-
nance and survival. First, it is notable that hESCs
show preferential differentiation into neuroectoderm,
and this property has been considered a ‘‘default’’ path-
way. Second, the chromosomal abnormalities seen
most commonly in hESCs involve trisomies of chromo-
somes 12 and 17, and these are most frequently ob-
served in trypinized cultures, which result in single-cell
suspensions during passage. Two of the genes identi-
fied as being involved in hESC maintenance by Pyle
et al., NT3 and p75NGFR, are located on chromosomes
12 and 17, respectively, suggesting that the frequency
of these chromosomal abnormalities could result from
selective pressure to increase neurotrophin signaling
in culture.
The discovery of neurotrophin influence in the re-
newal and maintenance of hESCs may highlight an im-
portant mechanism in the maintenance of embryonic
pluripotentiality of the ICM, which is used to form
hESCs, and explain the absence of apoptosis in mam-
malian embryos. Position of cells and memory of axis
are critical for patterning events in early development.
The inhibition of apoptosis is logical as a mechanism
to maintain growth in appropriate directions to enable
the formation of tissue structures. The relationship be-
tween cells by cell surface signaling would be needed
to enable growth patterns and apoptotic events in for-
mation of the embryonic organism.
Some of the most exciting implications for this study
are for future hESC research. Targeted mutagenesis
in hESCs has been very challenging and inefficientbecause of the inability to clone individual hESCs.
Consequently, it has been difficult to produce gene
‘‘knockouts’’ or ‘‘knockins’’ for use in functional geno-
mics and for the introduction of reporter genes into en-
dogenous promoter sequences of interest for analysis
of differentiation pathways. It has also been difficult to
sort individual cells stained with fluorescent antibodies
to enrich cultures for particular cell phenotypes. The use
of neurotrophin cultures with improved clonal survival
and genomic stability could assist in all of these areas
of stem cell biology. It seems likely that neurotrophins
will become a routine component of culture media
used for hESC and their differentiating derivatives. Ba-
sic fibroblast growth factor (bFGF) is considered essen-
tial for hESC cell culture, and attempts have been made
to grow hESCs in high concentrations of bFGF in
feeder-free cultures (Xu et al., 2005). The augmentation
of bulk cultures enabled by activation of bFGF and neu-
rotrophin signaling pathways will facilitate research in-
volving hESCs and their potential clinical applications
for stem cell-based therapies.
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